Application of tamsulosin in the prevention of postoperative urinary retention during laparoscopic transabdominal preperitoneal approach inguinal herniorrhaphy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045142

Enrollment

Unknown

Registered

2021-04-07

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary retention after TAPP for inguinal hernia

Interventions

Tamsulosin intervention group:tamsulosin

Placebo control group:placebo

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patients 18 years of age or older receiving elective TAPP.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of neurobladder requiring routine intermittent catheterization; 2.Patients undergoing emergency laparoscopic herniorrhaphy or elective laparoscopic herniorrhaphy accompanied by additional procedures (e.g., nephrectomy, pelvic surgery) that require planned indwelling of catheters during and after surgery; 3.Patients who have taken tamsulosin before surgery.

Design outcomes

Secondary

Measure	Time frame
Residual urine volume in the bladder;	—

Countries

China

Contacts

Public ContactYu Yongjiang

The First Clinical Medical College of Lanzhou University

ylongy@163.com+86 13993173828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026